Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Puma Biotechnology (PBYI) Other Non Operating Income (2017 - 2025)

Historic Other Non Operating Income for Puma Biotechnology (PBYI) over the last 9 years, with Q3 2025 value amounting to $115000.0.

  • Puma Biotechnology's Other Non Operating Income fell 6685.88% to $115000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year decrease of 672.06%. This contributed to the annual value of $862000.0 for FY2024, which is 1357.05% up from last year.
  • Puma Biotechnology's Other Non Operating Income amounted to $115000.0 in Q3 2025, which was down 6685.88% from $410000.0 recorded in Q2 2025.
  • In the past 5 years, Puma Biotechnology's Other Non Operating Income registered a high of $22.5 million during Q4 2021, and its lowest value of -$204000.0 during Q4 2022.
  • Over the past 5 years, Puma Biotechnology's median Other Non Operating Income value was $86000.0 (recorded in 2023), while the average stood at $1.3 million.
  • The largest annual percentage gain for Puma Biotechnology's Other Non Operating Income in the last 5 years was 41421.57% (2023), contrasted with its biggest fall of 18400.0% (2023).
  • Over the past 5 years, Puma Biotechnology's Other Non Operating Income (Quarter) stood at $22.5 million in 2021, then crashed by 100.91% to -$204000.0 in 2022, then soared by 414.22% to $641000.0 in 2023, then crashed by 58.19% to $268000.0 in 2024, then tumbled by 57.09% to $115000.0 in 2025.
  • Its last three reported values are $115000.0 in Q3 2025, $410000.0 for Q2 2025, and $359000.0 during Q1 2025.